Sandra Milligan
2021
In 2021, Sandra Milligan earned a total compensation of $4.1M as EVP and Head of Research & Development at Organon & Co..
Compensation breakdown
| Non-Equity Incentive Plan | $492,083 |
|---|---|
| Option Awards | $1,257,861 |
| Salary | $670,357 |
| Stock Awards | $1,611,914 |
| Other | $43,149 |
| Total | $4,075,364 |
Milligan received $1.6M in stock awards, accounting for 40% of the total pay in 2021.
Milligan also received $492.1K in non-equity incentive plan, $1.3M in option awards, $670.4K in salary and $43.1K in other compensation.
Rankings
In 2021, Sandra Milligan's compensation ranked 3,294th out of 12,406 executives tracked by ExecPay. In other words, Milligan earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,294 out of 12,406 | 73rd |
Division Manufacturing | 1,338 out of 5,494 | 76th |
Major group Chemicals And Allied Products | 543 out of 2,369 | 77th |
Industry group Drugs | 482 out of 2,090 | 77th |
Industry Pharmaceutical Preparations | 334 out of 1,537 | 78th |
Source: SEC filing on April 28, 2022.
Milligan's colleagues
We found four more compensation records of executives who worked with Sandra Milligan at Organon & Co. in 2021.